ASXL1 and acute myeloid leukemia: Mutations in these genes, along with ASXL1, are observed in pre-leukemic lesions and clonal hematopoiesis, supporting a stepwise mechanism for AML progression by which normal HSPCs acquire mutations in epigenetic modifiers before a transformative event such as an NPM1 driver mutation [59].